Cargando…

Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.

The preoperative concentrations of IgG were lower (P less than 0.002) and the concentrations of C4 and C1-INH higher (P less than 0.01 and P less than 0.001) in 29 patients with recurrence after potentially curative resection of gastric carcinoma, than in 31 patients alive and disease-free 5 years a...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen, C. W., Lie, R. T., Maartmann-Moe, H., Matre, R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247116/
https://www.ncbi.nlm.nih.gov/pubmed/2803929
_version_ 1782150912728367104
author Janssen, C. W.
Lie, R. T.
Maartmann-Moe, H.
Matre, R.
author_facet Janssen, C. W.
Lie, R. T.
Maartmann-Moe, H.
Matre, R.
author_sort Janssen, C. W.
collection PubMed
description The preoperative concentrations of IgG were lower (P less than 0.002) and the concentrations of C4 and C1-INH higher (P less than 0.01 and P less than 0.001) in 29 patients with recurrence after potentially curative resection of gastric carcinoma, than in 31 patients alive and disease-free 5 years after surgery. These differences between the two groups of patients were consistent within each of six groups of disease extent. In each of the two groups of patients, the preoperative concentrations of IgG, C4 and C1-INH had no significant variation with the extent of disease (P greater than 0.05 or greater). Of our variables, C1-INH was the most potent prognosticator and discriminated between patients with and without recurrence with 80% accuracy. Furthermore, the predictive prognostic value of C1-INH at the time of surgery was superior to the prognostic value of the extent of disease (F values 27.00 and 12.69). Apparently, the preoperative C1-INH concentration is an essential and independent prognostic parameter of gastric carcinoma. We assume that C1-INH reflects an additional prognostic feature appropriate to the tumour or the host. Our finding that the interval between surgery and death from recurrence had an inverse relation to the preoperative C1-INH concentration also supports this assumption.
format Text
id pubmed-2247116
institution National Center for Biotechnology Information
language English
publishDate 1989
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-22471162009-09-10 Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma. Janssen, C. W. Lie, R. T. Maartmann-Moe, H. Matre, R. Br J Cancer Research Article The preoperative concentrations of IgG were lower (P less than 0.002) and the concentrations of C4 and C1-INH higher (P less than 0.01 and P less than 0.001) in 29 patients with recurrence after potentially curative resection of gastric carcinoma, than in 31 patients alive and disease-free 5 years after surgery. These differences between the two groups of patients were consistent within each of six groups of disease extent. In each of the two groups of patients, the preoperative concentrations of IgG, C4 and C1-INH had no significant variation with the extent of disease (P greater than 0.05 or greater). Of our variables, C1-INH was the most potent prognosticator and discriminated between patients with and without recurrence with 80% accuracy. Furthermore, the predictive prognostic value of C1-INH at the time of surgery was superior to the prognostic value of the extent of disease (F values 27.00 and 12.69). Apparently, the preoperative C1-INH concentration is an essential and independent prognostic parameter of gastric carcinoma. We assume that C1-INH reflects an additional prognostic feature appropriate to the tumour or the host. Our finding that the interval between surgery and death from recurrence had an inverse relation to the preoperative C1-INH concentration also supports this assumption. Nature Publishing Group 1989-10 /pmc/articles/PMC2247116/ /pubmed/2803929 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Janssen, C. W.
Lie, R. T.
Maartmann-Moe, H.
Matre, R.
Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.
title Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.
title_full Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.
title_fullStr Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.
title_full_unstemmed Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.
title_short Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.
title_sort serum c1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247116/
https://www.ncbi.nlm.nih.gov/pubmed/2803929
work_keys_str_mv AT janssencw serumc1esteraseinhibitoranessentialandindependentprognosticatorofgastriccarcinoma
AT liert serumc1esteraseinhibitoranessentialandindependentprognosticatorofgastriccarcinoma
AT maartmannmoeh serumc1esteraseinhibitoranessentialandindependentprognosticatorofgastriccarcinoma
AT matrer serumc1esteraseinhibitoranessentialandindependentprognosticatorofgastriccarcinoma